MK-8237 (SCH900237) Biomarker Study in Participants With Allergic Rhinitis or Rhinoconjunctivitis (MK-8237-009)

Clinical trial NCT01852825 · COMPLETED

Trial details

NCT number: NCT01852825
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Allergic Rhinitis Allergic Rhinoconjunctivitis

Start date: 2013-11-27
Primary completion: 2015-07-20
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.